Visipaque

Visipaque (Iodixanol) is a non-ionic, iso-osmolar contrast agent used in medical imaging procedures. It enhances visibility of blood vessels and tissues during X-ray, CT, and MRI scans. Suitable for intraarterial, intravenous, and intrathecal use. Designed for clear, high-contrast imaging with low risk of side effects.

Iodixanol is primarily used as a contrast medium in diagnostic imaging to improve the visibility of internal body structures. It is commonly employed in procedures such as angiograms, CT scans, and myelograms. The agent helps radiologists identify abnormalities like blockages, tumors, or vascular issues. It is also used in intrathecal imaging to visualize the spinal cord and surrounding structures.

Visipaque works by temporarily increasing the density of certain tissues or fluids, making them appear brighter on imaging scans. This enhanced contrast allows for clearer and more detailed visualization of blood vessels, organs, and other structures. The effects are temporary and typically resolve as the agent is naturally cleared from the body. Most patients experience no noticeable effects beyond the imaging procedure itself.

Visipaque should only be administered by trained healthcare professionals in a clinical setting. Patients with a history of allergies, especially to iodine or contrast agents, should inform their provider. Adequate hydration before and after the procedure may help reduce the risk of side effects. Pregnant or breastfeeding individuals should discuss risks with their doctor prior to use.

Iodixanol may interact with certain medications, including metformin and some blood pressure drugs. Alcohol and other substances that affect kidney function could increase the risk of adverse effects. Always inform your healthcare provider about all medications and supplements you are taking. No known food interactions have been reported, but follow pre-procedure fasting guidelines.